These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 8384186

  • 1. Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture.
    Toubro S, Astrup AV, Breum L, Quaade F.
    Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S69-72. PubMed ID: 8384186
    [Abstract] [Full Text] [Related]

  • 2. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.
    Astrup A, Breum L, Toubro S, Hein P, Quaade F.
    Int J Obes Relat Metab Disord; 1992 Apr; 16(4):269-77. PubMed ID: 1318281
    [Abstract] [Full Text] [Related]

  • 3. The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans.
    Toubro S, Astrup A, Breum L, Quaade F.
    Int J Obes Relat Metab Disord; 1993 Dec; 17 Suppl 3():S73-7; discussion S82. PubMed ID: 8124407
    [Abstract] [Full Text] [Related]

  • 4. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.
    Breum L, Pedersen JK, Ahlstrøm F, Frimodt-Møller J.
    Int J Obes Relat Metab Disord; 1994 Feb; 18(2):99-103. PubMed ID: 8148931
    [Abstract] [Full Text] [Related]

  • 5. Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity.
    Daly PA, Krieger DR, Dulloo AG, Young JB, Landsberg L.
    Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S73-8. PubMed ID: 8384187
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.
    Molnár D, Török K, Erhardt E, Jeges S.
    Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1573-8. PubMed ID: 11126208
    [Abstract] [Full Text] [Related]

  • 7. The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet.
    Buemann B, Marckmann P, Christensen NJ, Astrup A.
    Int J Obes Relat Metab Disord; 1994 May; 18(5):329-32. PubMed ID: 8061726
    [Abstract] [Full Text] [Related]

  • 8. [The effect of an ephedrine/caffeine combination as a supplement to a weight-reducing diet. A randomized, placebo-controlled, double-blind trial].
    Quaade F, Astrup A, Breum L, Toubro S, Hein P.
    Ugeskr Laeger; 1992 Apr 27; 154(18):1258-63. PubMed ID: 1598695
    [No Abstract] [Full Text] [Related]

  • 9. Ephedrine as an anorectic: the story of the 'Elsinore pill'.
    Malchow-Møller A, Larsen S, Hey H, Stokholm KH, Juhl E, Quaade F.
    Int J Obes; 1981 Apr 27; 5(2):183-7. PubMed ID: 7228474
    [Abstract] [Full Text] [Related]

  • 10. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial.
    Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, Strauss R, Meredith T.
    Int J Obes Relat Metab Disord; 2002 May 27; 26(5):593-604. PubMed ID: 12032741
    [Abstract] [Full Text] [Related]

  • 11. Herbal simulation of ephedrine and caffeine in treatment of obesity.
    Dulloo AG.
    Int J Obes Relat Metab Disord; 2002 May 27; 26(5):590-2. PubMed ID: 12032740
    [No Abstract] [Full Text] [Related]

  • 12. A controlled trial using ephedrine in the treatment of obesity.
    Pasquali R, Baraldi G, Cesari MP, Melchionda N, Zamboni M, Stefanini C, Raitano A.
    Int J Obes; 1985 May 27; 9(2):93-8. PubMed ID: 3897082
    [Abstract] [Full Text] [Related]

  • 13. Clinical aspects of ephedrine in the treatment of obesity.
    Pasquali R, Casimirri F.
    Int J Obes Relat Metab Disord; 1993 Feb 27; 17 Suppl 1():S65-8. PubMed ID: 8384185
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacology of thermogenic drugs.
    Astrup A, Toubro S, Christensen NJ, Quaade F.
    Am J Clin Nutr; 1992 Jan 27; 55(1 Suppl):246S-248S. PubMed ID: 1345887
    [Abstract] [Full Text] [Related]

  • 15. Muscle uncoupling protein 3 expression is unchanged by chronic ephedrine/caffeine treatment: results of a double blind, randomised clinical trial in morbidly obese females.
    Bracale R, Petroni ML, Davinelli S, Bracale U, Scapagnini G, Carruba MO, Nisoli E.
    PLoS One; 2014 Jan 27; 9(6):e98244. PubMed ID: 24905629
    [Abstract] [Full Text] [Related]

  • 16. The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women.
    Astrup A, Buemann B, Christensen NJ, Toubro S, Thorbek G, Victor OJ, Quaade F.
    Metabolism; 1992 Jul 27; 41(7):686-8. PubMed ID: 1619985
    [Abstract] [Full Text] [Related]

  • 17. Ephedrine, caffeine and aspirin promote weight loss in obese subjects.
    Krieger DR, Daly PA, Dulloo AG, Ransil BJ, Young JB, Landsberg L.
    Trans Assoc Am Physicians; 1990 Jul 27; 103():307-12. PubMed ID: 2132541
    [No Abstract] [Full Text] [Related]

  • 18. The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent.
    Greenway FL.
    Obes Rev; 2001 Aug 27; 2(3):199-211. PubMed ID: 12120105
    [Abstract] [Full Text] [Related]

  • 19. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment.
    Coffey CS, Steiner D, Baker BA, Allison DB.
    Int J Obes Relat Metab Disord; 2004 Nov 27; 28(11):1411-9. PubMed ID: 15356670
    [Abstract] [Full Text] [Related]

  • 20. The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain.
    Nørregaard J, Jørgensen S, Mikkelsen KL, Tønnesen P, Iversen E, Sørensen T, Søeberg B, Jakobsen HB.
    Clin Pharmacol Ther; 1996 Dec 27; 60(6):679-86. PubMed ID: 8988071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.